University of Pittsburgh Medical School researchers walk us through multiple approaches they’ve tried in the past, are currently using or plan to use in the future, as well as the significant ...

A genetically engineered pig kidney helped Towana Looney enjoy 130 days without the need for dialysis before the organ was ...

Researchers have identified type 5 collagen as a key factor in kidney fibrosis, revealing its potential as a biomarker to predict chronic kidney disease progression. A repurposed anti-cancer drug, ...

(Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today ...

Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant ...

Okeiro raises €10 Million to accelerate development of its Precision Medicine platform for Transplantation and Chronic Diseases Paris, April 10, 2025 - Okeiro, a company specializing in precision ...

Paris, April 10, 2025 - Okeiro, a company specializing in precision medicine for transplantation and advanced chronic ...

A nephrologist argues that advancing kidney care in the US requires tailored guidelines addressing ethnic diversity & fragmented healthcare.

Unicycive Therapeutics (UNCY) announced new patient-reported outcomes data from its pivotal Phase 2 study of OLC as well as from a new survey ...

Palatin Technologies, Inc. , a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced that ...

In March, two biotechnology companies were given the greenlight by the Food and Drug Administration, or FDA, to conduct ...